Bioventus Inc.
BVS
$7.46
-$0.14-1.84%
NASDAQ
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.70% | 382.86% | -1,590.38% | 96.98% | 79.89% |
| Total Depreciation and Amortization | -5.36% | 1.55% | 165.87% | -246.75% | -6.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.31% | 125.32% | -92.23% | 828.55% | -83.50% |
| Change in Net Operating Assets | 2,138.36% | 101.53% | -1,380.12% | -360.26% | -108.26% |
| Cash from Operations | 16.04% | 234.18% | -200.05% | 87.30% | -31.96% |
| Capital Expenditure | 30.75% | 17.31% | -43.90% | -796.88% | 16.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.45% | -65.74% | -103.43% | 37,762.50% | 16.88% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -206.04% | 0.00% | 89.64% | -- | 100.00% |
| Issuance of Common Stock | -92.71% | 778.00% | -86.40% | 99.46% | -9.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -507.19% | -19.31% | -313.73% | 2,354.45% | -0.53% |
| Cash from Financing | -36.24% | -1,648.36% | 102.21% | -11,938.40% | 104.61% |
| Foreign Exchange rate Adjustments | -295.05% | -53.02% | 120.84% | -542.70% | 211.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.45% | 153.82% | -1,158.71% | -113.47% | 62.44% |